| Year |
Citation |
Score |
| 2011 |
Morgan D, Munireddy S, Alamed J, DeLeon J, Diamond DM, Bickford P, Hutton M, Lewis J, McGowan E, Gordon MN. Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice Advances in Alzheimer's Disease. 1: 129-138. DOI: 10.3233/978-1-60750-733-8-129 |
0.574 |
|
| 2010 |
Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, Dickson DW, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 10851-9. PMID 20702714 DOI: 10.1523/Jneurosci.1630-10.2010 |
0.697 |
|
| 2010 |
Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, ... McGowan E, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. The American Journal of Pathology. 177: 311-24. PMID 20522652 DOI: 10.2353/Ajpath.2010.090915 |
0.676 |
|
| 2010 |
Salek RM, Xia J, Innes A, Sweatman BC, Adalbert R, Randle S, McGowan E, Emson PC, Griffin JL. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochemistry International. 56: 937-47. PMID 20398713 DOI: 10.1016/J.Neuint.2010.04.001 |
0.379 |
|
| 2010 |
Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, ... McGowan E, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging (American Journal of Pathology (2010), 177, (311-324)) American Journal of Pathology. 177: 2146. DOI: 10.2353/Ajpath.2010.100772 |
0.655 |
|
| 2010 |
Xu Y, Gendron T, Zhang Y, Lin W, D'Alton S, Sheng H, Crook R, Casey MC, Tong J, Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, et al. P1-185: Wild-type human TDP-43 induces mitochondrial abnormalities and axonal degeneration in transgenic mice Alzheimer's & Dementia. 6: S227-S227. DOI: 10.1016/J.Jalz.2010.05.735 |
0.641 |
|
| 2010 |
Ahmed Z, Sheng H, Xu Y, Lin W, Innes AE, Yu X, Hou H, Chiba S, Yamanouchi K, Petrucelli L, Nishihara M, Hutton ML, McGowan E, Dickson DW, Lewis J. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggests a role for progranulin in successful aging Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.249 |
0.571 |
|
| 2010 |
Lewis J, Xu Y, Cannon A, Zhang Y, Lin W, Hutton M, McGowan E, Dickson DW, Petrucelli L. O1-04-04: TDP-43 mouse models: Tools toward understanding the normal and disease roles for TDP-43 Alzheimer's & Dementia. 6: S77-S77. DOI: 10.1016/J.Jalz.2010.05.228 |
0.495 |
|
| 2009 |
Adams SJ, Crook RJ, Deture M, Randle SJ, Innes AE, Yu XZ, Lin WL, Dugger BN, McBride M, Hutton M, Dickson DW, McGowan E. Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. The American Journal of Pathology. 175: 1598-609. PMID 19717642 DOI: 10.2353/Ajpath.2009.090462 |
0.664 |
|
| 2009 |
Pereson S, Wils H, Kleinberger G, McGowan E, Vandewoestyne M, Van Broeck B, Joris G, Cuijt I, Deforce D, Hutton M, Van Broeckhoven C, Kumar-Singh S. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. The Journal of Pathology. 219: 173-81. PMID 19557827 DOI: 10.1002/Path.2580 |
0.643 |
|
| 2009 |
Cook C, Gass J, Dunmore J, Tong J, Taylor J, Eriksen J, McGowan E, Lewis J, Johnston J, Petrucelli L. Aging is not associated with proteasome impairment in UPS reporter mice. Plos One. 4: e5888. PMID 19517018 DOI: 10.1371/Journal.Pone.0005888 |
0.566 |
|
| 2009 |
Lewis JM, Ahmed Z, Sheng H, Xu Y, Lin W, Innes A, Hou H, Hutton ML, McGowan E, Dickson DW. O4-06-01: Neuropathological characterization of progranulin-deficient mice: Accelerated lipofuscin accumulation suggests a role for progranulin in successful aging Alzheimer's & Dementia. 5: P161-P162. DOI: 10.1016/J.Jalz.2009.05.558 |
0.393 |
|
| 2009 |
Pereson S, Kleinberger G, Wils H, McGowan E, Jucker M, Deforce D, Broeckhoven CV, Kumar-Singh S. Progranulin correlates with dense-core plaque burden in Alzheimer's disease mouse models Alzheimers & Dementia. 5: 83. DOI: 10.1016/J.Jalz.2009.05.211 |
0.404 |
|
| 2008 |
Morgan D, Munireddy S, Alamed J, DeLeon J, Diamond DM, Bickford P, Hutton M, Lewis J, McGowan E, Gordon MN. Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice. Journal of Alzheimer's Disease : Jad. 15: 605-14. PMID 19096159 DOI: 10.3233/Jad-2008-15407 |
0.645 |
|
| 2008 |
Matsuda S, Giliberto L, Matsuda Y, McGowan EM, D'Adamio L. BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8668-76. PMID 18753367 DOI: 10.1523/Jneurosci.2094-08.2008 |
0.37 |
|
| 2008 |
Stokin GB, Almenar-Queralt A, Gunawardena S, Rodrigues EM, Falzone T, Kim J, Lillo C, Mount SL, Roberts EA, McGowan E, Williams DS, Goldstein LS. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Human Molecular Genetics. 17: 3474-86. PMID 18694898 DOI: 10.1093/Hmg/Ddn240 |
0.65 |
|
| 2008 |
Paulson JB, Ramsden M, Forster C, Sherman MA, McGowan E, Ashe KH. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease. The American Journal of Pathology. 173: 762-72. PMID 18669616 DOI: 10.2353/Ajpath.2008.080175 |
0.569 |
|
| 2008 |
Verbeeck C, Cannon-Crews A, Jansen-West K, Ceballos-Diaz C, McGowan E, Golde TE, Kukar TL. P1-052: Somatic brain transgenic TDP-43 mice Alzheimer's & Dementia. 4: T221-T221. DOI: 10.1016/J.Jalz.2008.05.638 |
0.415 |
|
| 2008 |
Pereson S, Vandewoestyne M, Broeck BV, Cuijt I, Peeters E, Ceuterick C, McGowan E, Jucker M, Broeckhoven CV, Deforce D, Kumar-Singh S. P4-300: Gene expression profiling to identify microvascular changes in Alzheimer's disease mouse models Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2369 |
0.357 |
|
| 2008 |
Adams SJ, Dugger B, Innes A, Randle SJ, Yu C, Crook RJ, Hutton M, McGowan E, Dickson DW. P2-172: Wild-type mouse tau transgenic model: Halfway to a complete AD model Alzheimer's & Dementia. 4: T421-T421. DOI: 10.1016/J.Jalz.2008.05.1246 |
0.439 |
|
| 2007 |
Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, Dickson DW, Golde T, McGowan E. Abeta40 inhibits amyloid deposition in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 627-33. PMID 17234594 DOI: 10.1523/Jneurosci.4849-06.2007 |
0.732 |
|
| 2006 |
Levites Y, Smithson LA, Price RW, Dakin RS, Yuan B, Sierks MR, Kim J, McGowan E, Reed DK, Rosenberry TL, Das P, Golde TE. Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2576-8. PMID 17068112 DOI: 10.1096/Fj.06-6463Fje |
0.698 |
|
| 2006 |
Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, ... ... McGowan E, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442: 916-9. PMID 16862116 DOI: 10.1038/Nature05016 |
0.545 |
|
| 2006 |
Le Corre S, Klafki HW, Plesnila N, Hübinger G, Obermeier A, Sahagún H, Monse B, Seneci P, Lewis J, Eriksen J, Zehr C, Yue M, McGowan E, Dickson DW, Hutton M, et al. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 9673-8. PMID 16769887 DOI: 10.1073/Pnas.0602913103 |
0.621 |
|
| 2006 |
Pickford F, Coomaraswamy J, Jucker M, McGowan E. Modeling familial British dementia in transgenic mice. Brain Pathology (Zurich, Switzerland). 16: 80-5. PMID 16612985 DOI: 10.1111/J.1750-3639.2006.Tb00564.X |
0.481 |
|
| 2006 |
McGowan E, Eriksen J, Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trends in Genetics : Tig. 22: 281-9. PMID 16567017 DOI: 10.1016/J.Tig.2006.03.007 |
0.58 |
|
| 2006 |
Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. The Journal of Clinical Investigation. 116: 193-201. PMID 16341263 DOI: 10.1172/Jci25410 |
0.557 |
|
| 2006 |
Lewis J, Zehr C, Knight J, Dickson DW, Hutton M, McGowan E. P1-117: Kinetics of tau suppression in the rTg4510 inducible model of tauopathy Alzheimer's & Dementia. 2: S129-S130. DOI: 10.1016/J.Jalz.2006.05.493 |
0.53 |
|
| 2006 |
Kim J, Onstead L, Smithson L, Price R, Randle S, Yu C, Dickson D, Golde T, McGowan E. P1-113: The Abeta42/Abeta40 ratio, not total Abeta level, controls amyloid deposition in transgenic mice Alzheimer's & Dementia. 2: S128-S129. DOI: 10.1016/J.Jalz.2006.05.489 |
0.718 |
|
| 2006 |
Janus C, Kim J, Hanna A, Wilson J, Price R, Dickson D, Golde T, McGowan E. O4-05-05: Dissociation between amyloid pathology and memory impairment Alzheimer's & Dementia. 2: S85-S86. DOI: 10.1016/J.Jalz.2006.05.331 |
0.632 |
|
| 2006 |
Lewis J, Zehr C, Andorfer C, Eriksen J, Knight J, Yue M, Robinson T, Berger Z, Hanna A, Dickson DW, Janus C, McGowan E, Hutton M. O4-05-01: Methods of cell death and recovery in the rTg4510 and iP301L inducible mouse models of tauopathy Alzheimer's & Dementia. 2: S84-S84. DOI: 10.1016/J.Jalz.2006.05.327 |
0.458 |
|
| 2006 |
Hutton M, Melquist S, Baker M, Zehr C, McGowan E, Dickson D, Eriksen J, Ashe K, Stephan D, Lewis J. S2-02-06: The tauopathies: From genetics to animal models Alzheimer's & Dementia. 2: S26-S26. DOI: 10.1016/J.Jalz.2006.05.086 |
0.444 |
|
| 2005 |
Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, Guimaraes A, Yue M, Lewis J, Carlson G, Hutton M, Ashe KH. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10637-47. PMID 16291936 DOI: 10.1523/Jneurosci.3279-05.2005 |
0.624 |
|
| 2005 |
Kumar-Singh S, Pirici D, McGowan E, Serneels S, Ceuterick C, Hardy J, Duff K, Dickson D, Van Broeckhoven C. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. The American Journal of Pathology. 167: 527-43. PMID 16049337 DOI: 10.1016/S0002-9440(10)62995-1 |
0.695 |
|
| 2005 |
McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 47: 191-9. PMID 16039562 DOI: 10.1016/J.Neuron.2005.06.030 |
0.78 |
|
| 2005 |
Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science (New York, N.Y.). 309: 476-81. PMID 16020737 DOI: 10.1126/Science.1113694 |
0.567 |
|
| 2004 |
Hutton M, McGowan E. Clearing tau pathology with Abeta immunotherapy--reversible and irreversible stages revealed. Neuron. 43: 293-4. PMID 15294135 DOI: 10.1016/J.Neuron.2004.07.023 |
0.633 |
|
| 2004 |
Sahara N, Vega IE, Ishizawa T, Lewis J, McGowan E, Hutton M, Dickson D, Yen SH. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins. Journal of Neurochemistry. 90: 829-38. PMID 15287888 DOI: 10.1111/J.1471-4159.2004.02558.X |
0.63 |
|
| 2004 |
Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Research. 1012: 29-41. PMID 15158158 DOI: 10.1016/J.Brainres.2004.02.081 |
0.636 |
|
| 2004 |
Garcia MF, Gordon MN, Hutton M, Lewis J, McGowan E, Dickey CA, Morgan D, Arendash GW. The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice. Neuroreport. 15: 73-7. PMID 15106834 DOI: 10.1097/00001756-200401190-00015 |
0.491 |
|
| 2004 |
Zehr C, Lewis J, McGowan E, Crook J, Lin WL, Godwin K, Knight J, Dickson DW, Hutton M. Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice. Neurobiology of Disease. 15: 553-62. PMID 15056463 DOI: 10.1016/J.Nbd.2003.12.011 |
0.569 |
|
| 2004 |
Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Human Molecular Genetics. 13: 703-14. PMID 14962978 DOI: 10.1093/Hmg/Ddh083 |
0.759 |
|
| 2004 |
Hutton M, Melrose H, Zehr C, McGowan E, Dickson DW, Yen S, Kehoe K, Taylor J, Eriksen J, Petrucelli L, Lewis J. P4-422 Mechanism of neurofibrillary degeneration in a mouse model of tauopathy and progress towards identification of a therapeutic target Neurobiology of Aging. 25: S594. DOI: 10.1016/S0197-4580(04)81978-X |
0.512 |
|
| 2004 |
Horsburgh KJ, Pickford F, Kennedy L, Lewis J, Hutton M, McGowan E. P3-253 Temporal alterations in tau and apolipoprotein E after hippocampal denervation in mutant tau mice: a preliminary investigation Neurobiology of Aging. 25: S426-S427. DOI: 10.1016/S0197-4580(04)81403-9 |
0.605 |
|
| 2004 |
Petrucelli L, Taylor J, Kehoe K, Lewis J, McGowan E, Snyder H, Wolozin B, Dawson TM, Dillmann W, Voellmy R, Hutton M. P3-228 Chip and HSP70 regulate tau ubiquitination, degradation and aggregation Neurobiology of Aging. 25: S419-S420. DOI: 10.1016/S0197-4580(04)81378-2 |
0.642 |
|
| 2004 |
Bailey C, Pickord F, Lewis J, Heckman M, Yue M, O'Donnell K, Yu C, Hutton M, McGowan E. P2-095 The effect of ovariectomy on pathology and phenotype in Tau (P301L) transgenic mice Neurobiology of Aging. 25: S251. DOI: 10.1016/S0197-4580(04)80842-X |
0.634 |
|
| 2004 |
Pickford F, Onstead-Cardinale L, Eriksen J, Murphy P, Pritam D, Kim J, Dolios G, Wang R, Dickson DW, Golde T, McGowan E. P2-090 ABETA42 is required for amyloid deposition in transgenic mice Neurobiology of Aging. 25: S249. DOI: 10.1016/S0197-4580(04)80837-6 |
0.645 |
|
| 2004 |
Zehr C, Godwin K, Lin W, Dickson DW, McGowan E, Lewis J, Hutton M. P2-070 Axonal degeneration in P301L Tau transgenic mice Neurobiology of Aging. 25: S243-S244. DOI: 10.1016/S0197-4580(04)80817-0 |
0.584 |
|
| 2003 |
Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. The American Journal of Pathology. 163: 1057-67. PMID 12937146 DOI: 10.1016/S0002-9440(10)63465-7 |
0.65 |
|
| 2003 |
Pickford F, Onstead L, Camacho-Prihar C, Hardy J, McGowan E. Expression of mBRI2 in mice. Neuroscience Letters. 338: 95-8. PMID 12566161 DOI: 10.1016/S0304-3940(02)01356-3 |
0.482 |
|
| 2002 |
Sahara N, Lewis J, DeTure M, McGowan E, Dickson DW, Hutton M, Yen SH. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. Journal of Neurochemistry. 83: 1498-508. PMID 12472903 DOI: 10.1046/J.1471-4159.2002.01241.X |
0.618 |
|
| 2002 |
O'Farrell C, Pickford F, Vink L, McGowan E, Cookson MR. Sequence conservation between mouse and human synphilin-1. Neuroscience Letters. 322: 9-12. PMID 11958831 DOI: 10.1016/S0304-3940(02)00068-X |
0.498 |
|
| 2001 |
Hutton M, Lewis J, Dickson D, Yen SH, McGowan E. Analysis of tauopathies with transgenic mice. Trends in Molecular Medicine. 7: 467-70. PMID 11597522 DOI: 10.1016/S1471-4914(01)02123-2 |
0.64 |
|
| 2001 |
Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (New York, N.Y.). 293: 1487-91. PMID 11520987 DOI: 10.1126/Science.1058189 |
0.72 |
|
| 2001 |
Lewis PA, Piper S, Baker M, Onstead L, Murphy MP, Hardy J, Wang R, McGowan E, Golde TE. Expression of BRI-amyloid beta peptide fusion proteins: a novel method for specific high-level expression of amyloid beta peptides. Biochimica Et Biophysica Acta. 1537: 58-62. PMID 11476963 DOI: 10.1016/S0925-4439(01)00054-0 |
0.626 |
|
| 2001 |
Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston WJ, McGowan E, Farrer M, Hardy J, Duff K, Przedborski S, Di Monte DA. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiology of Disease. 8: 535-9. PMID 11442360 DOI: 10.1006/Nbdi.2001.0392 |
0.675 |
|
| 2001 |
Hernandez D, Sugaya K, Qu T, McGowan E, Duff K, McKinney M. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes. Neuroreport. 12: 1377-84. PMID 11388415 DOI: 10.1097/00001756-200105250-00018 |
0.641 |
|
| 2000 |
Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, Wood NW, Kumar-Singh S, Geddes J, Swash M, Scaravilli F, Holton JL, Lashley T, Tomita T, Hashimoto T, et al. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Annals of Neurology. 48: 806-8. PMID 11079548 DOI: 10.1002/1531-8249(200011)48:5<806::Aid-Ana18>3.0.Co;2-F |
0.685 |
|
| 2000 |
Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genetics. 25: 402-5. PMID 10932182 DOI: 10.1038/78078 |
0.728 |
|
| 2000 |
Hardy JA, Houlden H, Baker M, McGowan E, Lewis P, Prihar G, Sing S, Martin J. High A42 causing presenilin 1 mutations lead to the cotton wool plaques/spastic paraparesis variant of Alzheimer's disease Neurobiology of Aging. 21: 212. DOI: 10.1016/S0197-4580(00)83282-0 |
0.337 |
|
| 2000 |
Lewis PA, McGowan E, Hardy JA, Golde TE. Specific production of Aß peptides from BRI-Aß fusion proteins Neurobiology of Aging. 21: 199. DOI: 10.1016/S0197-4580(00)82238-1 |
0.445 |
|
| 1999 |
McGowan E, Sanders S, Iwatsubo T, Takeuchi A, Saido T, Zehr C, Yu X, Uljon S, Wang R, Mann D, Dickson D, Duff K. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiology of Disease. 6: 231-44. PMID 10448051 DOI: 10.1006/Nbdi.1999.0243 |
0.673 |
|
| 1999 |
Prihar G, Gonzalez de Chavez F, Baker M, Crook R, McGowan E, Grover A, Hardy J, Hutton M. A novel candidate presenilin-1 interacting protein containing tetratricopeptide repeats. Neuroreport. 10: 1409-15. PMID 10380955 DOI: 10.1097/00001756-199905140-00005 |
0.534 |
|
| 1998 |
Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Medicine. 4: 97-100. PMID 9427614 DOI: 10.1038/Nm0198-097 |
0.679 |
|
| 1997 |
Benkovic SA, McGowan EM, Rothwell NJ, Hutton M, Morgan DG, Gordon MN. Regional and cellular localization of presenilin-2 RNA in rat and human brain. Experimental Neurology. 145: 555-64. PMID 9217091 DOI: 10.1006/Exnr.1997.6487 |
0.446 |
|
| Show low-probability matches. |